Baxalta Inc
USPTO Trademark & Patent Filings
Trademark applications and grants for Baxalta Inc. Baxalta Inc has 94 trademark applications. The latest application filed is for "a symbol or image mark"
| Patent Application | Date |
|---|---|
| THERAPEUTIC PROTEINS WITH INCREASED HALF-LIFE AND METHODS OF PREPARING SAME 20220175939 - 17/677926 Siekmann; Juergen ; et al. | 2022-06-09 |
| LYOPHILIZED RECOMBINANT VWF FORMULATIONS 20210308227 - 16/258488 Schnecker; Kurt ; et al. | 2021-10-07 |
| TREATMENT OF ALZHEIMER'S DISEASE SUBPOPULATIONS WITH POOLED IMMUNOGLOBULIN G 20210238267 - 17/234658 Gelmont; David M. ; et al. | 2021-08-05 |
| COMBINATION THERAPY OF ANTI-MIF ANTIBODIES AND GLUCOCORTICOIDS 20210187105 - 17/139772 Kerschbaumer; Randolf ; et al. | 2021-06-24 |
| TREATMENT OF GASTROINTESTINAL BLEEDING IN PATIENTS WITH SEVERE VON WILLEBRAND DISEASE BY ADMINISTRATION OF RECOMBINANT VWF 20210169989 - 17/108562 Chapman; Miranda ; et al. | 2021-06-10 |
| SEC | 0001620546 | Baxalta Inc of DELAWARE |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 